Sandborn WJ - Search Results

1

Is antibody testing for inflammatory bowel disease clinically useful?

Panaccione R, Sandborn WJ. Panaccione R, et al. Among authors: sandborn wj. Gastroenterology. 1999 Apr;116(4):1001-2; discussion 1002-3. doi: 10.1016/s0016-5085(99)70087-9. Gastroenterology. 1999. PMID: 10092326 No abstract available.

2

The appendix in ulcerative colitis: a not so innocent bystander.

Panaccione R, Sandborn WJ. Panaccione R, et al. Among authors: sandborn wj. Gastroenterology. 1999 Jul;117(1):272-3. doi: 10.1016/s0016-5085(99)70581-0. Gastroenterology. 1999. PMID: 10381940 No abstract available.

3

Successful management of Crohn's disease of the ileoanal pouch with infliximab.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Gastroenterology. 1999 Aug;117(2):429-32. doi: 10.1053/gast.1999.0029900429. Gastroenterology. 1999. PMID: 10419926

4

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541

5

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. Schwartz DA, et al. Among authors: sandborn wj. Gastroenterology. 2002 Apr;122(4):875-80. doi: 10.1053/gast.2002.32362. Gastroenterology. 2002. PMID: 11910338

6

Biologic therapy of inflammatory bowel disease.

Sandborn WJ, Targan SR. Sandborn WJ, et al. Gastroenterology. 2002 May;122(6):1592-608. doi: 10.1053/gast.2002.33426. Gastroenterology. 2002. PMID: 12016425 Review.

7

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.

Ricart E, Panaccione R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2004 May;10(3):207-14. doi: 10.1097/00054725-200405000-00005. Inflamm Bowel Dis. 2004. PMID: 15290913

8

Medical therapy of Crohn disease.

Panaccione R, Sandborn WJ. Panaccione R, et al. Among authors: sandborn wj. Curr Opin Gastroenterol. 2004 Jul;20(4):351-9. doi: 10.1097/00001574-200407000-00009. Curr Opin Gastroenterol. 2004. PMID: 15703664

9

Natalizumab induction and maintenance therapy for Crohn's disease.

Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts P; International Efficacy of Natalizumab as Active Crohn's Therapy (ENACT-1) Trial Group; Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group. Sandborn WJ, et al. N Engl J Med. 2005 Nov 3;353(18):1912-25. doi: 10.1056/NEJMoa043335. N Engl J Med. 2005. PMID: 16267322 Free article. Clinical Trial.

10

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Hanauer SB, et al. Among authors: sandborn wj. Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030. Gastroenterology. 2006. PMID: 16472588 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

950 results

Search Page

Filters